Full course description
Direct Oral Anticoagulants (DOACs) have quickly become attractive alternatives to the long‐standing standard of care in anticoagulation, vitamin K antagonist. DOACs are indicated for prevention and treatment of several cardiovascular conditions. Since the first approval in 2010, DOACs have emerged as leading therapeutic alternatives that provide both clinicians and patients with more effective, safe, and convenient treatment options in thromboembolic settings. With the expanding role of DOACs, clinicians are faced with increasingly complex decisions relating to appropriate agent, duration of treatment, and use in special populations.
The aim of this course is to delve into the subject of DOACs and consider the numerous forms in which they are available, their specific uses, and precautions related to their use.
Clint Shedd is a certified FNP and is a clinical associate professor at Emory University Nell Hodgson Woodruff School of Nursing. He holds a DNP, MN, and BSN from Georgia Regents University and a BFA from the University of Georgia.
Prior to his faculty position, Dr. Shedd worked in pulmonary practice, and he currently works in allergy/immunology care as a nurse practitioner. Additionally, Dr. Shedd has published in the areas of VTE prophylaxis, anaphylaxis, COPD management, and in the care of acute asthma exacerbations.
Emory Nursing Professional Development Center (ENPDC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Attendees to this CNE activity will be awarded 1.25 Continuing Nursing Education contact hours (including 1.25 Pharmacotherapeutic) from ENPDC.
Need Help with Registration? Please contact us at firstname.lastname@example.org or 404-727-9208